Robeco Institutional Asset Management Reduces Hologic Stake

Institutional investor sells off over half its position in medical equipment provider Hologic, Inc.

Apr. 18, 2026 at 9:34am

A highly detailed, cinematic macro photograph of the inner workings of Hologic medical equipment, showcasing the complex engineering and manufacturing behind the company's diagnostic and imaging technologies.An extreme close-up of the intricate machinery powering Hologic's advanced medical devices reflects the company's technological sophistication.Marlborough Today

Robeco Institutional Asset Management B.V. has reduced its stake in Hologic, Inc. (NASDAQ:HOLX) by 57.4% during the fourth quarter, according to a recent regulatory filing. The fund now owns 11,563 shares of the medical equipment provider's stock, down from 27,163 shares previously.

Why it matters

Hologic is a major player in the medical technology industry, specializing in women's health products such as digital mammography systems and molecular diagnostics. Changes in institutional ownership of the company's stock can provide insights into broader market sentiment and investment trends within the healthcare sector.

The details

Robeco Institutional Asset Management, a Dutch investment firm, sold 15,600 shares of Hologic stock during the fourth quarter, reducing its total position to 11,563 shares worth $861,000. The move comes as Hologic's stock price has hovered around $75-$76 per share in recent months, close to its 52-week high. Other institutional investors have also made modest adjustments to their Hologic holdings, with some adding to their positions and others trimming exposure.

  • Robeco Institutional Asset Management reduced its Hologic stake during the fourth quarter of 2025.
  • Hologic's stock price has traded in the $75-$76 range in recent months, near its 52-week high.

The players

Robeco Institutional Asset Management B.V.

A Dutch investment management firm that has reduced its stake in medical equipment provider Hologic, Inc.

Hologic, Inc.

A global medical technology company specializing in women's health products such as digital mammography systems and molecular diagnostics.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Robeco's Hologic stake suggests some institutional investors may be taking a more cautious approach to the medical equipment provider's stock, even as the company continues to be a major player in the women's health technology market.